QIAGEN
QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics.QIAGEN offers its sample and assay consumable products in kit form.
QIAGEN
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
1986-01-01
Address:
Venlo, Limburg, The Netherlands
Country:
The Netherlands
Website Url:
http://www.qiagen.com
Total Employee:
1001+
Status:
Active
Contact:
+31 77 320 8400
Total Funding:
4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Board_member
Current Employees Featured
Carsten Knaut Head of HR (Digital) Transformation @ Qiagen
Head of HR (Digital) Transformation
Marta Herreros Clinical Study Lead @ Qiagen
Clinical Study Lead
2020-08-01
Metin Colpan CEO @ Qiagen
CEO
Richard Watts Vice President, Business Development, Companion Diagnostics @ Qiagen
Vice President, Business Development, Companion Diagnostics
2012-11-01
Stephane Bancel Supervisory Director @ Qiagen
Supervisory Director
Reinhard Ortmann Director Companion Diagnostics @ Qiagen
Director Companion Diagnostics
2010-07-01
Thierry Bernard Chief Executive Officer @ Qiagen
Chief Executive Officer
2019-10-01
David Heffelfinger Site Manager & Sr. Director of Engineering @ Qiagen
Site Manager & Sr. Director of Engineering
2014-01-01
Lilly Kong Sr. Director, Assay Development @ Qiagen
Sr. Director, Assay Development
2014-04-01
Dan Richards VP Biomedical Informatics & Ingenuity @ Qiagen
VP Biomedical Informatics & Ingenuity
2013-05-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-11 | BLIRT | BLIRT acquired by Qiagen | N/A |
| 2020-09-17 | NeuMoDx Molecular | NeuMoDx Molecular acquired by Qiagen | 248 M USD |
| 2019-01-07 | N-of-One | N-of-One acquired by Qiagen | N/A |
| 2018-11-01 | Parsagen | Parsagen acquired by Qiagen | N/A |
| 2018-02-01 | STAT-Dx | STAT-Dx acquired by Qiagen | 191 M USD |
| 2017-01-09 | OmicSoft Corp. | OmicSoft Corp. acquired by Qiagen | N/A |
| 2015-11-01 | MO BIO Laboratories | MO BIO Laboratories acquired by Qiagen | N/A |
| 2014-06-05 | PrimeraDx (Primera Biosystems) | PrimeraDx (Primera Biosystems) acquired by Qiagen | N/A |
| 2014-05-21 | BIOBASE | BIOBASE acquired by Qiagen | N/A |
| 2013-10-25 | CLC bio | CLC bio acquired by Qiagen | N/A |
Investors List
U.S. Department of Health & Human Services
U.S. Department of Health & Human Services investment in Grant - Qiagen
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Qiagen
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-19 | Glyphic Biotechnologies | Qiagen investment in Grant - Glyphic Biotechnologies | 40 K USD |
| 2021-07-01 | Actome | Qiagen investment in Seed Round - Actome | N/A |
| 2018-03-20 | ArcherDX | Qiagen investment in Series A - ArcherDX | 35 M USD |
| 2016-01-07 | Exosome Diagnostics | Qiagen investment in Series B - Exosome Diagnostics | 16 M USD |
| 2014-12-17 | Protagen | Qiagen investment in Venture Round - Protagen | 10 M EUR |
| 2014-03-11 | Exosome Diagnostics | Qiagen investment in Series B - Exosome Diagnostics | 27 M USD |
| 2013-01-08 | Drug Response Dx | Qiagen investment in Series A - Drug Response Dx | N/A |
| 2012-01-30 | Xagenic | Qiagen investment in Series A - Xagenic | 10 M USD |
| 1999-08-03 | Coley Pharmaceutical Group | Qiagen investment in Series B - Coley Pharmaceutical Group | 12.9 M USD |
| 1998-06-01 | Ingenium Pharmaceuticals AG | Qiagen investment in Seed Round - Ingenium Pharmaceuticals AG | N/A |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-24 | QIAGEN Names Thierry Bernard as Chief Executive Officer |
Official Site Inspections
http://www.qiagen.com Semrush global rank: 146.6 K Semrush visits lastest month: 591.44 K
- Host name: 20.105.224.28
- IP address: 20.105.224.28
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Qiagen"
Our vision - QIAGEN
Our global QIAGEN team is known to more than 500,000 customers around the world across the continuum from research in the life sciences to molecular diagnostics and public safety applications in everyday use. But Sample to …See details»
Qiagen - Wikipedia
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters …See details»
Sample to Insight - QIAGEN
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.See details»
Qiagen N.V. - Home
QIAGEN N.V. verpflichtet sich, Ihre Daten mit Respekt zu behandeln und sie nicht an Dritte weiterzugeben. Sie können alle von Ihnen abonnierten Investor Alerts abbestellen, indem Sie …See details»
Business and Operating Environment | Financial Report 2019
The consumable products manufactured at QIAGEN GmbH in Germany, and QIAGEN Sciences LLC in Maryland, are produced under ISO 9001: 2008, ISO 13485:2012, ISO 13485:2003 …See details»
Qiagen - Crunchbase Company Profile & Funding
Qiagen announced a strategy to achieve solid profitable growth by 2028, targeting a 7% annual sales growth. The company also reported higher profitability and the development of more AI-enabled applications by 2028. Qiagen's first quarter …See details»
QIAGEN and Myriad Genetics partner to advance companion …
QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial …See details»
QIAGEN Corporate - Bioinformatics Software | QIAGEN Digital …
QIAGEN offers you the industry’s most reliable sample technologies. Our top-quality assays and panels enable you to accurately analyze and identify diseases and genetic variations. Our …See details»
QIAGEN - LinkedIn
QIAGEN | 281,424 followers on LinkedIn. QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples …See details»
A focus on five pillars | Financial Report 2020 - Qiagen
…how QIAGEN is addressing diversity… Jonathan Sheldon It’s critical that the whole organization engages on this. For that to happen, people also have to feel safe in expressing their opinions and views – respectfully and thoughtfully. …See details»
Our Views - QIAGEN
QIAGEN Views – Insights from our leadership team. Michael Flossdorf, Head of Data Science and AI at QIAGEN . AI is here to stay. AI is a multifaceted tool with vast potential – but realizing its …See details»
Our global presence - QIAGEN
QIAGEN operates 35 subsidiaries across over 25 countries, supported by a global distribution partner network spanning more than 60 countries. Our team of over 6,000 employees delivers …See details»
Qiagen N.V. - QIAGEN and SOPHiA GENETICS forge partnership to …
Mar 1, 2023 About QIAGEN. QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable …See details»
Qiagen Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Qiagen has 5 employees across 49 locations and $1.97 b in annual revenue in FY 2023. See insights on Qiagen including office locations, competitors, revenue, financials, …See details»
Bioinformatics Software | QIAGEN Digital Insights
QIAGEN Digital Insights is here to help you achieve success. With an unrivalled, superior quality knowledge base powered by augmented molecular intelligence (AMI) and a comprehensive …See details»
Historical Development - QIAGEN
QIAGEN (originally Diagen) was born as a spin-out from the Heinrich-Heine University in Dusseldorf in 1984. Founded by the three young scientists, Metin Colpan, Karsten Henco, and …See details»
Qiagen N.V. - QIAGEN reaches milestone with its kits used to …
Aug 23, 2021 Milestone underlines company’s global leadership in sample preparation Company’s NGS assays also hit milestone of one million samples tested since 2015 New kits …See details»
Why QIAGEN
QIAGEN develops individuals in many different ways because people are so different and their talents so diverse. The company’s training and development philosophy is a mix of …See details»
QIAGEN reaches milestone with 100 million QuantiFERON tests …
Mar 24, 2022 On World TB Day, milestone confirms blood test as gold standard in global fight against the disease Accurate testing can help prevent 1.5 million TB deaths annually QIAGEN …See details»
Qiagen N.V. - QIAGEN Strengthens QIAstat-Dx With New …
4 days ago BARCELONA, Spain & VENLO, the Netherlands--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to move its QIAstat-Dx …See details»